نتایج جستجو برای: cardiac hypertrophy

تعداد نتایج: 305267  

Journal: :Circulation research 2003
Yasuhiro Izumiya Shokei Kim Yasukatsu Izumi Kaoru Yoshida Minoru Yoshiyama Atsushi Matsuzawa Hidenori Ichijo Hiroshi Iwao

Multiple lines of evidence establish that angiotensin II (Ang II) induces not only hypertension but also directly contributes to cardiac diseases. Apoptosis signal-regulating kinase 1 (ASK1), one of mitogen-activated protein kinase kinase kinases, plays a key role in stress-induced cellular responses. However, nothing is known about the role of ASK1 in cardiac hypertrophy and remodeling in vivo...

Journal: :Cell 2013
Francesco S. Loffredo Matthew L. Steinhauser Steven M. Jay Joseph Gannon James R. Pancoast Pratyusha Yalamanchi Manisha Sinha Claudia Dall’Osso Danika Khong Jennifer L. Shadrach Christine M. Miller Britta S. Singer Alex Stewart Nikolaos Psychogios Robert E. Gerszten Adam J. Hartigan Mi-Jeong Kim Thomas Serwold Amy J. Wagers Richard T. Lee

The most common form of heart failure occurs with normal systolic function and often involves cardiac hypertrophy in the elderly. To clarify the biological mechanisms that drive cardiac hypertrophy in aging, we tested the influence of circulating factors using heterochronic parabiosis, a surgical technique in which joining of animals of different ages leads to a shared circulation. After 4 week...

Journal: :Hypertension 2014
Liangpeng Li Wen Chen Yifan Zhu Xiaodi Wang Ding-Sheng Jiang Fuhua Huang Liming Wang Fei Xiang Wei Qin Qiang Wang Rui Zhang Xueyong Zhu Hongliang Li Xin Chen

Caspase recruitment domain 6 (CARD6), a crucial member of the CARD family, was initially shown to be involved in the immune system and oncogenesis. However, the role of CARD6 in chronic pressure overload-induced cardiac hypertrophy remains unexplored. To evaluate the impact of CARD6 on pathological cardiac hypertrophy, cardiac-specific CARD6 knockout mice and transgenic mice with cardiac-specif...

Journal: :The Journal of clinical investigation 2008
Hong-Liang Li Chen Liu Geoffrey de Couto Maral Ouzounian Mei Sun Ai-Bing Wang Yue Huang Cheng-Wei He Yu Shi Xin Chen Mai P Nghiem Youan Liu Manyin Chen Fayez Dawood Masahiro Fukuoka Yuichiro Maekawa Liyong Zhang Andrew Leask Asish K Ghosh Lorrie A Kirshenbaum Peter P Liu

Chromatin remodeling, particularly histone acetylation, plays a critical role in the progression of pathological cardiac hypertrophy and heart failure. We hypothesized that curcumin, a natural polyphenolic compound abundant in the spice turmeric and a known suppressor of histone acetylation, would suppress cardiac hypertrophy through the disruption of p300 histone acetyltransferase-dependent (p...

Journal: :Hypertension 2015
Yuanjie Mao Takeshi Tokudome Ichiro Kishimoto Kentaro Otani Hirohito Nishimura Osamu Yamaguchi Kinya Otsu Mikiya Miyazato Kenji Kangawa

Cardiac hypertrophy, which is commonly caused by hypertension, is a major risk factor for heart failure and sudden death. Endogenous ghrelin has been shown to exert a beneficial effect on cardiac dysfunction and postinfarction remodeling via modulation of the autonomic nervous system. However, ghrelin's ability to attenuate cardiac hypertrophy and its potential mechanism of action are unknown. ...

2017
Xiurong Li Yuhuai Lan Yan Wang Minghao Nie Yanhong Lu Eryang Zhao

Telmisartan, a type of angiotensin II (Ang II) receptor inhibitor, is a common agent used to treat hypertension in the clinic. Hypertension increases cardiac afterload and promotes cardiac hypertrophy. However, the ventricular Ang II receptor may be activated in the absence of hypertension. Therefore, telmisartan may reduce cardiac hypertrophy by indirectly ameliorating hypertensive symptoms an...

2017
Jiani C. Yin Mathew J. Platt Xixi Tian Xue Wu Peter H. Backx Jeremy A. Simpson Toshiyuki Araki Benjamin G. Neel

Noonan syndrome (NS) is caused by mutations in RAS/ERK pathway genes, and is characterized by craniofacial, growth, cognitive and cardiac defects. NS patients with kinase-activating RAF1 alleles typically develop pathological left ventricular hypertrophy (LVH), which is reproduced in Raf1L613V/+ knock-in mice. Here, using inducible Raf1L613V expression, we show that LVH results from the interpl...

Journal: :Cardiovascular research 1999
K C Wollert H Drexler

Experimental studies suggest that the renin-angiotensin system (RAS) and its primary effector peptide, angiotensin II (Ang II), are involved in the pathophysiology of cardiac hypertrophy and failure. All the components required for Ang II production are present in the heart, and cardiac Ang II formation appears to be regulated independent from the circulating RAS. In animal models and in patien...

2014
Jianchun Huang XiaoJun Tang Xingmei Liang Qingwei Wen Shijun Zhang Feifei Xuan Jie Jian Xing Lin Renbin Huang

We investigated the effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone (MHBFC), which was isolated from the roots of Millettia pulchra (Benth.) Kurz var. Laxior (Dunn) Z.Wei (Papilionaceae) (MKL), on the progression of cardiac hypertrophy to failure in a rat model of abdominal aortic banding (AAB)-induced pressure overloading. Endothelial dysfunction is central to pressure overload-induced ...

Journal: :Circulation 2008
Masayuki Taniike Osamu Yamaguchi Ikuko Tsujimoto Shungo Hikoso Toshihiro Takeda Atsuko Nakai Shigemiki Omiya Isamu Mizote Yuko Nakano Yoshiharu Higuchi Yasushi Matsumura Kazuhiko Nishida Hidenori Ichijo Masatsugu Hori Kinya Otsu

BACKGROUND Mechanical stress on the heart can lead to crucially different outcomes. Physiological stimuli such as exercise cause adaptive cardiac hypertrophy, characterized by a normal cardiac structure and normal or enhanced cardiac function. Pathological stimuli such as hypertension and aortic valvular stenosis cause maladaptive cardiac remodeling and ultimately heart failure. Apoptosis signa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید